Dermbits

Dermbits

Welcome to Dermbits! Watch short videos of KOLs answering your questions
How do comorbidities affect the decision to prescribe ruxolitinib for vitiligo?
0:40
Apr 2, 2025Vitiligo

How do comorbidities affect the decision to prescribe ruxolitinib for vitiligo?

-

Are there any benefits to using ruxolitinib in combination with narrowband UVB for vitiligo?
0:37
Apr 2, 2025Vitiligo

Are there any benefits to using ruxolitinib in combination with narrowband UVB for vitiligo?

-

How does repigmentation progress over time with ruxolitinib treatment?
0:45
Apr 2, 2025Vitiligo

How does repigmentation progress over time with ruxolitinib treatment?

-

Are there any emerging technologies or diagnostic tools that can enhance the early detection of vitiligo?
1:08
Apr 2, 2025Vitiligo

Are there any emerging technologies or diagnostic tools that can enhance the early detection of vitiligo?

-

What is the outlook on microneedling for vitiligo?
0:48
Apr 2, 2025Vitiligo

What is the outlook on microneedling for vitiligo?

-

What are some of the dermoscopic features of vitiligo?
0:29
Apr 2, 2025Vitiligo

What are some of the dermoscopic features of vitiligo?

-

Is there any long-term safety data available for lebrikizumab?
0:36
Apr 1, 2025Atopic Dermatitis

Is there any long-term safety data available for lebrikizumab?

-

How long should patients remain on lebrikizumab to achieve optimal long-term control of their atopic dermatitis symptoms?
0:57
Apr 1, 2025Atopic Dermatitis

How long should patients remain on lebrikizumab to achieve optimal long-term control of their atopic dermatitis symptoms?

-

Is lebrikizumab appropriate for patients who have failed other biologics?
0:51
Apr 1, 2025Atopic Dermatitis

Is lebrikizumab appropriate for patients who have failed other biologics?

-

Did any patients in clinical trials for lebrikizumab achieve EASI90?
0:44
Apr 1, 2025Atopic Dermatitis

Did any patients in clinical trials for lebrikizumab achieve EASI90?

-

How does lebrikizumab fit into proactive vs reactive AD treatment approaches?
0:53
Apr 1, 2025Atopic Dermatitis

How does lebrikizumab fit into proactive vs reactive AD treatment approaches?

-

Should lebrikizumab be used as monotherapy or can it be combined with other treatments?
0:53
Apr 1, 2025Atopic Dermatitis

Should lebrikizumab be used as monotherapy or can it be combined with other treatments?

-

What are the practical considerations for incorporating lebrikizumab into long-term treatment plans?
1:06
Apr 1, 2025Atopic Dermatitis

What are the practical considerations for incorporating lebrikizumab into long-term treatment plans?

-

What is the importance of early intervention in preventing disease progression in atopic dermatitis?
1:01
Apr 1, 2025Atopic Dermatitis

What is the importance of early intervention in preventing disease progression in atopic dermatitis?

-

How should dermatologists sequence topical and systemic treatments in patients with refractory atopic dermatitis?
1:16
Apr 1, 2025Atopic Dermatitis

How should dermatologists sequence topical and systemic treatments in patients with refractory atopic dermatitis?

-

How can dermatologists tailor treatment plans for patients with frequent infections related to atopic dermatitis?
1:18
Apr 1, 2025Atopic Dermatitis

How can dermatologists tailor treatment plans for patients with frequent infections related to atopic dermatitis?

-

Why is ruxolitinib uniquely suited to treat vitiligo compared to other JAK inhibitors?
0:35
Mar 3, 2025Vitiligo

Why is ruxolitinib uniquely suited to treat vitiligo compared to other JAK inhibitors?

-

How does ruxolitinib compare to topical corticosteroids and topical calcineurin inhibitors for vitiligo?
0:49
Mar 3, 2025Vitiligo

How does ruxolitinib compare to topical corticosteroids and topical calcineurin inhibitors for vitiligo?

-

Does the efficacy of ruxolitinib for vitiligo vary across Fitzpatrick skin types?
0:34
Mar 3, 2025Vitiligo

Does the efficacy of ruxolitinib for vitiligo vary across Fitzpatrick skin types?

-

What rate of facial repigmentation was seen in clinical trials for ruxolitinib in patients with vitiligo?
0:50
Mar 3, 2025Vitiligo

What rate of facial repigmentation was seen in clinical trials for ruxolitinib in patients with vitiligo?

-

How frequently should dermatologists follow up with patients taking ruxolitinib for vitiligo?
0:42
Mar 3, 2025Vitiligo

How frequently should dermatologists follow up with patients taking ruxolitinib for vitiligo?

-

What strategies can dermatologists use to improve patient adherence to ruxolitinib for vitiligo?
0:50
Mar 3, 2025Vitiligo

What strategies can dermatologists use to improve patient adherence to ruxolitinib for vitiligo?

-

Is there a risk of systemic absorption with ruxolitinib for vitiligo?
0:37
Mar 3, 2025Vitiligo

Is there a risk of systemic absorption with ruxolitinib for vitiligo?

-

What are some therapies that are currently in the pipeline for the treatment of vitiligo?
1:03
Mar 3, 2025Vitiligo

What are some therapies that are currently in the pipeline for the treatment of vitiligo?

-